Your browser doesn't support javascript.
loading
Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years.
D'Angelo, Natália A; Noronha, Mariana A; Câmara, Mayra C C; Kurnik, Isabelle S; Feng, Chuying; Araujo, Victor H S; Santos, João H P M; Feitosa, Valker; Molino, João V D; Rangel-Yagui, Carlota O; Chorilli, Marlus; Ho, Emmanuel A; Lopes, André M.
Afiliação
  • D'Angelo NA; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
  • Noronha MA; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
  • Câmara MCC; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
  • Kurnik IS; School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
  • Feng C; Laboratory for Drug Delivery and Biomaterials, School of Pharmacy, University of Waterloo, 10 Victoria St S, Kitchener, Ontario N2G1C5, Canada.
  • Araujo VHS; School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
  • Santos JHPM; Department of Biochemical and Pharmaceutical Technology, University of São Paulo (USP), São Paulo, Brazil; Micromanufacturing Laboratory, Center for Bionanomanufacturing, Institute for Technological Research (IPT), São Paulo, Brazil.
  • Feitosa V; Micromanufacturing Laboratory, Center for Bionanomanufacturing, Institute for Technological Research (IPT), São Paulo, Brazil.
  • Molino JVD; Ronin Institute, Montclair, NJ, USA.
  • Rangel-Yagui CO; Department of Biochemical and Pharmaceutical Technology, University of São Paulo (USP), São Paulo, Brazil.
  • Chorilli M; School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
  • Ho EA; Laboratory for Drug Delivery and Biomaterials, School of Pharmacy, University of Waterloo, 10 Victoria St S, Kitchener, Ontario N2G1C5, Canada.
  • Lopes AM; Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, Brazil. Electronic address: amlopes@unicamp.br.
Biomater Adv ; 133: 112623, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35525766
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Biomater Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Biomater Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Holanda